mk 0663 has been researched along with Malignant Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feist, J; Murray, A; Schulze-Koops, H; Skapenko, A | 1 |
| Becker, A; Dömkes, S; Hillen, U; Livingstone, E; Schadendorf, D; Zimmer, L | 1 |
1 trial(s) available for mk 0663 and Malignant Melanoma
| Article | Year |
|---|---|
Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arthralgia; Disease Progression; Dose-Response Relationship, Drug; Drug Eruptions; Etoricoxib; Female; Humans; Imidazoles; Indoles; Lymphatic Metastasis; Melanoma; Middle Aged; Neoplasm Staging; Oximes; Panniculitis; Point Mutation; Proto-Oncogene Proteins B-raf; Pyridines; Skin Neoplasms; Sulfonamides; Sulfones; Vemurafenib | 2012 |
1 other study(ies) available for mk 0663 and Malignant Melanoma
| Article | Year |
|---|---|
A Rare Side Effect of Checkpoint Inhibitor Therapy-Nivolumab-Induced Axial Polyarthritis of the Facet and Costovertebral Joints.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Immunological; Etoricoxib; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Nivolumab; Prednisolone; Range of Motion, Articular; Ribs; Skin Neoplasms; Spondylarthritis; Sternocostal Joints; Treatment Outcome; Zygapophyseal Joint | 2019 |